FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants
Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
Nationwide Blood Pressure Drug Recall As FDA Issues Fatal Warning
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
A drug got recalled after someone saw ‘black matter’ that can cause stroke or death
“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in ...
ConsumerAffairs4 日
Drug used to treat low blood pressure recalled
Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...
Pharmabiz1 日
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride: Cork, Ireland Thursday, January 30, 2025, 10:00 Hrs [IST] C2 PHARMA, the global leader in manufacturing ...
thecardiologyadvisor.com2 日
Provepharm Recalls 1 Lot of Phenylephrine HCl Injection
Provepharm Inc. is recalling 1 lot of Phenylephrine HCl Injection, USP 10mg/mL due to presence of particulate matter in the product.
KVOE1 日
Chase County deputies make arrest in drug distribution, conspiracy case
Chase County deputies say they have arrested a man for an outstanding drug-related warrant.